# Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

> **NCT01607073** · PHASE2 · COMPLETED · sponsor: **Gillette Children's Specialty Healthcare** · enrollment: 2 (actual)

## Conditions studied

- Dravet Syndrome

## Interventions

- **DRUG:** Verapamil

## Key facts

- **NCT ID:** NCT01607073
- **Lead sponsor:** Gillette Children's Specialty Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2021-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607073, "Verapamil as Therapy for Children and Young Adults With Dravet Syndrome". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01607073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*